Walleye Capital LLC Cure Vac N.V. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $409,191 - $883,923	177,139 Added 1650.41%	187,872 $638,000
Q1 2024 May 15, 2024	SELL	$2.94 - $4.34 $2.22 Million - $3.28 Million	-755,582 Reduced 98.6%	10,733 $32,000
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $1.46 Million - $2.37 Million	369,685 Added 93.21%	766,315 $3.23 Million
Q3 2023 Nov 14, 2023	BUY	$6.5 - $10.77 $2.58 Million - $4.27 Million	396,630 New	396,630 $2.71 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.